Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

Alzheimer's disease (AD) pathology is estimated to develop many years before detectable cognitive decline. Fluid and imaging biomarkers may identify people in early symptomatic and even preclinical stages, possibly when potential treatments can best preserve cognitive function. We previously re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fagan, Anne M, Mintun, Mark A, Shah, Aarti R, Aldea, Patricia, Roe, Catherine M, Mach, Robert H, Marcus, Daniel, Morris, John C, Holtzman, David M
Natura: Artigo
Lingua:Inglês
Pubblicazione: WILEY-VCH Verlag 2009
Soggetti:
Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806678/
https://ncbi.nlm.nih.gov/pubmed/20049742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.200900048
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi